His primary areas of study are Multiple myeloma, Internal medicine, Surgery, Cancer and Bortezomib. His studies in Multiple myeloma integrate themes in fields like Bone disease and Bone marrow, Pathology. His studies deal with areas such as Immunology, Endocrinology and Oncology as well as Internal medicine.
When carried out as part of a general Surgery research project, his work on Fever of unknown origin, Neutropenia and Absolute neutrophil count is frequently linked to work in Cefepime, therefore connecting diverse disciplines of study. His research on Cancer also deals with topics like
Orhan Sezer mostly deals with Multiple myeloma, Internal medicine, Oncology, Cancer research and Surgery. His Multiple myeloma research incorporates elements of Bone disease and Bone marrow, Pathology. His work deals with themes such as Gastroenterology and Endocrinology, which intersect with Internal medicine.
His Oncology study integrates concerns from other disciplines, such as Gemcitabine, Hematopoietic stem cell transplantation, Metastatic breast cancer and Autologous stem-cell transplantation. His Cancer research research is multidisciplinary, incorporating elements of Apoptosis, Osteoclast and Cell growth. He interconnects Cancer and Quality of life in the investigation of issues within Surgery.
Orhan Sezer spends much of his time researching Multiple myeloma, Internal medicine, Oncology, Surgery and Bortezomib. His Multiple myeloma research includes themes of Cancer research, Bone disease and Transplantation. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology.
As a part of the same scientific study, Orhan Sezer usually deals with the Oncology, concentrating on Stage and frequently concerns with Multivariate analysis. His Surgery research incorporates themes from Cancer, Tolerability and Urology. His study looks at the relationship between Bortezomib and topics such as Proteasome inhibitor, which overlap with Cell cycle.
Orhan Sezer mainly focuses on Multiple myeloma, Internal medicine, Surgery, Oncology and Cancer. The various areas that Orhan Sezer examines in his Multiple myeloma study include Bone disease and Transplantation. Internal medicine is closely attributed to Immunology in his study.
In his study, Psychometrics and Colorectal cancer is strongly linked to Clinical trial, which falls under the umbrella field of Oncology. His Cancer research includes elements of Physical therapy and Quality of life. His Bortezomib research integrates issues from Cancer research and Adverse effect, Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz;Ray Comenzo;Rodney H. Falk;Jean Paul Fermand.
American Journal of Hematology (2005)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.
R Fonseca;P L Bergsagel;J Drach;J Shaughnessy.
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel.
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson.
Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
Andreas Engert;Volker Diehl;Jeremy Franklin;Andreas Lohri.
Journal of Clinical Oncology (2009)
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
Meletios A. Dimopoulos;Evangelos Terpos;Asher Chanan-Khan;Nelson Leung.
Journal of Clinical Oncology (2010)
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil Munshi;Nikhil Munshi;Kenneth Carl Anderson;Leif Bergsagel;John Shaughnessy.
Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)
Antonio Palumbo;Sara Bringhen;Heinz Ludwig;Meletios A. Dimopoulos.
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
J.M Blazeby;T Conroy;E Hammerlid;P Fayers.
European Journal of Cancer (2003)
International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease
Evangelos Terpos;Gareth Morgan;Meletios Athanasios Dimopoulos;Matthew T. Drake.
Journal of Clinical Oncology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: